5-[(2-Methoxyphenoxy)-methyl]-2-oxazolidinone
CAS: 70-07-5
Rif. 3D-FM25063
2mg | 136,00 € | ||
5mg | 184,00 € | ||
10mg | 281,00 € | ||
25mg | 452,00 € | ||
50mg | 723,00 € |
Informazioni sul prodotto
- Mephenoxalone5-(o-Methoxyphenoxymethyl)-2-oxazolidinoneMetoxadone
- 2-Oxazolidinone, 5-[(2-methoxyphenoxy)methyl]-
- 2-Oxazolidinone, 5-[(o-methoxyphenoxy)methyl]-
- 5-(2-Methoxyphenoxymethyl)-2-Oxazolidone
- 5-(o-Methoxyphenoxymethyl)-2-oxazolidinone
- 5-(o-Methoxyphenoxymethyl)-2-oxazolidone
- 5-[(2-Methoxyphenoxy)Methyl]-1,3-Oxazolidin-2-One
- 5-[(2-Methoxyphenoxy)methyl]-2-oxazolidinone
- Ahr 233
- Control-OM
- Vedi altri sinonimi
- Dorsiflex
- Dorsilon
- Ekilan
- Lenetran
- Lenetran Tab
- Lenetranat
- Methoxadone
- Methoxydon
- Methoxydone
- Metoxadon
- Metoxadone
- Moderamin
- Om-518
- Placidex
- Riself
- Tranpoise
- Trepidone
- Valans
- Xerene
5-[(2-Methoxyphenoxy)-methyl]-2-oxazolidinone is a pharmacological agent that is structurally similar to rapamycin. It has been shown to inhibit the production of creatine kinase in rat liver microsomes and has been used in studies on degenerative diseases. 5-[(2-Methoxyphenoxy)-methyl]-2-oxazolidinone inhibits the activity of polymerase chain reaction (PCR) by binding to the DNA polymerase and blocking the extension of an oligonucleotide primer. It has also been shown to be toxic to humans, as it can cause fatty acid accumulation and a clinical response. In addition, this drug is enantiopure, meaning that it is composed of only one type of molecule with a specific configuration. The analytical chemistry for this drug includes gas chromatography (GC) and high performance liquid chromatography (HPLC).
Proprietà chimiche
Richiesta tecnica su: 3D-FM25063 5-[(2-Methoxyphenoxy)-methyl]-2-oxazolidinone
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.